Definitive Treatment for Todani Classification of Choledochal Cysts
All choledochal cysts with malignant potential (Types I, II, and IV) require complete surgical excision with Roux-en-Y hepaticojejunostomy and cholecystectomy, while Type III cysts (choledochocele) can be managed endoscopically with sphincterotomy, and Type V cysts (Caroli disease) may require liver transplantation for diffuse disease. 1, 2
Treatment Algorithm by Todani Type
Type I (Fusiform/Saccular Extrahepatic Bile Duct Dilatation)
- Surgical approach: Complete excision of the extrahepatic bile duct and gallbladder, followed by Roux-en-Y hepaticojejunostomy 1, 3, 4
- Rationale: Type I cysts carry significant malignancy risk (3-7.5%) and are associated with biliary obstruction, stone formation, and cholangitis 1, 3
- Critical point: Incomplete excision leaves residual cyst tissue that maintains malignancy risk—drainage procedures alone are obsolete 5, 4
Type II (Diverticulum of Extrahepatic Bile Duct)
- Surgical approach: Simple excision of the diverticulum 4, 6
- Rationale: These are true diverticula requiring only local excision without need for biliary reconstruction
Type III (Choledochocele - Intraduodenal Cyst)
- Endoscopic approach: ERCP with endoscopic sphincterotomy is first-line treatment 4, 6, 7, 8
- Surgical alternative: For larger lesions or failed endoscopic management, consider laparoscopic cholecystectomy with Roux-en-Y hepaticojejunostomy 8
- Key distinction: Type III is the only choledochal cyst routinely managed non-surgically, though endoscopic treatment should be limited to smaller lesions 2, 6
Type IV (Multiple Cysts - Both Intra- and Extrahepatic)
- Type IVA (multiple intra- and extrahepatic cysts): Complete excision of extrahepatic component with Roux-en-Y hepaticojejunostomy; intrahepatic cysts may require partial hepatectomy if localized 1, 3
- Type IVB (multiple extrahepatic cysts only): Complete excision with Roux-en-Y hepaticojejunostomy 3
- Critical consideration: Type IV carries particularly high malignancy risk and requires aggressive surgical management 1
Type V (Caroli Disease - Intrahepatic Cysts Only)
- Localized disease: Hepatic resection of affected segments 9
- Diffuse disease: Liver transplantation is the definitive treatment 10, 9
- Important caveat: Type V falls outside typical choledochal cyst management and represents a distinct therapeutic challenge—interventional drainage is only temporizing 9
Critical Management Principles
Malignancy surveillance is mandatory even after complete excision. Despite surgical resection reducing cancer risk, metachronous malignancy occurs in 0.7-40% of cases (median 5.6%), primarily within the first 20 years post-resection 1. The 2025 EASL guidelines recommend:
- Liver function tests and CA19-9 annually for 20 years (then biannually)
- Ultrasound biannually for 20 years (then every 3 years) 1
Common pitfall: Cyst enterostomy or internal drainage procedures are obsolete and contraindicated—they leave residual cyst epithelium with persistent malignancy risk and recurrent symptoms 5, 4. Historical drainage procedures have been abandoned in favor of complete excision.
Timing consideration: Single-stage complete excision is the goal for Types I, II, and IV 4. Emergency presentations with cholangitis or biliary peritonitis may require initial drainage with delayed definitive reconstruction after 4-6 weeks once inflammation is controlled 11.
Technical note: Minimally invasive (laparoscopic) approaches are increasingly used for Types I and III with acceptable morbidity and mortality, though these complex cases should be managed at high-volume hepatopancreaticobiliary centers 5, 8.
Five-year survival after appropriate choledochal cyst excision is 95.5%, underscoring the importance of complete surgical resection for appropriate cyst types 3.